Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
43.5M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
+3.17M
-
Total reported value, excl. options
-
$960M
-
Value change
-
+$85.3M
-
Number of buys
-
82
-
Number of sells
-
-37
-
Price
-
$19.87
Significant Holders of Beta Bionics, Inc. - Common Stock (BBNX) as of Q3 2025
140 filings reported holding BBNX - Beta Bionics, Inc. - Common Stock as of Q3 2025.
Beta Bionics, Inc. - Common Stock (BBNX) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (4.96M shares), FARALLON CAPITAL MANAGEMENT LLC (4.31M shares), WELLINGTON MANAGEMENT GROUP LLP (3.9M shares), Soleus Capital Management, L.P. (3.87M shares), MORGAN STANLEY (3.76M shares), Sands Capital Alternatives, LLC (3.57M shares), RTW INVESTMENTS, LP (3.3M shares), BlackRock, Inc. (2.78M shares), VANGUARD GROUP INC (2.22M shares), and Omega Fund Management, LLC (1.92M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.